USPTO serial 79354308
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others for pharmaceutical products; scientific research in the nature of conducting clinical trials for others in the fields of cardiovascular disease, cardiology, oncology, orthopedics, ophthalmology, endocrinology, respiratory, immunology, dermatology, neurology, cell and gene therapy, pain and vaccines; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; clinical research in the fields of cardiology, oncology, orthopedics, ophthalmology, endocrinology, respiratory, immunology, dermatology, neurology, cell and gene therapy, pain and vaccines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biological research, clinical research in the fields of cardiology, oncology, orthopedics, ophthalmology, endocrinology, respiratory, immunology, dermatology, neurology, cell and gene therapy, pain and vaccines, and medical research; biomedical research services; biotechnological research; biotechnology research; scientific research in the fields of cardiology, oncology, orthopedics, ophthalmology, endocrinology, respiratory, immunology, dermatology, neurology, cell and gene therapy, pain and vaccines; scientific research; biological research services; medical research services; scientific research services; research of pharmaceuticals; pharmaceutical research services; research relating to pharmaceuticals | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 11, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 21, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 20, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 12, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 12, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 26, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 26, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 6, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 6, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 17, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2023 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 25, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 25, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 25, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 25, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 25, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 25, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 23, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 22, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |